Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory




  Products Center
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan HCl Trihydrate 99.5%
Etoposide USP31
Palonosetron Hydrochloride
  N-1 stage of Paclitaxel and Docetaxel
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
Ethyl (2R,3S)-3-Phenylisoserine Ester
Your location >>Home>>About us>>profile
Shanghai Jinhe Bio-Pharmaceutical Co., Ltd. (Abrr. "Jinhe") , founded in March 2002, is a pharmaceutical enterprise dedicated to R&D, manufacturing and marketing anti-cancer APIs and their intermediates. Based on the R&D achievement of Fudan University, we began to undertake the international business of processing Paclitaxel API. After years of effort, we successfully developed Paclitaxel, Docetaxel, Irinotecan, Etoposide etc, from natural extracting anti-cancer products into material source anti-cancer APIs. In recent years, we developed new APIs, such as Cabazitaxel, Palonosetron hydrochloride etc. In 2012, we cooperated with Shanghai Zhongxi Sunve Pharmaceutical Co.,Ltd, (Abrr. "Sunve") became a member of Shanghai Pharmaceuticals Holding Co.,Ltd. (Abrr. "SPH"). Since then, we targeted ourselves as the production base of SPH on oncology products. In 2015, we and Shanghai Huayu Chinese Herbs Co., Ltd. (Abrr. "Huayu") both subsidiaries of SPH, reorganized Dali Zhonggu Yew Biological Co., Ltd. (Abrr. "Zhonggu Biological") by way of investment in cash. This move indicates that SPH will further integrate its oncology drug industry chain and build its advantage in APIs. In January 2017, we achieved GMP certificate on Bulk Drug (Paclitaxel, Docetaxel). We are always committed to be a competitive and responsible company in global pharmaceutical industry.

CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE
疯狂之七电子游戏 股票融资率 快乐10分走势图 孝感卡五星麻将群 北京pk赛车稳赚技巧 广东11选五官网 澳洲幸运10开奖 北京pk10技巧规律后8码 吉林十一选五基本走势 现在做代理赚钱免费的 北京pk10冠军走势图 456棋牌游戏大厅安卓版 海南飞鱼彩票销售点 全天飞艇免费计划一期 快三大小单双技巧揭秘 买六肖中奖看哪个 老时时彩开奖历史结果